Massive Bio helps pre-screen patients for top clinical trials, which streamlines the trial enrollment process and reduces clinical staff time, thereby reducing screen failures.

Breast Cancer Trial
Breast Cancer Trial

A phase 2, non-randomized clinical trial for patients with metastatic breast cancers harboring FGFR amplifications.

  • Phase 2 Study
  • Sex: All
  • Age 18+
  • Non-Randomized
  • 168 Participants
Cervical Cancer Trial
Cervical Cancer Trial

A phase 2, randomized clinical trial for patients with squamous-cell carcinoma, adenosquamous carcinoma, or adenocarcinoma of the cervix, and metastatic, locally advanced, and/or unresectable disease.

  • Phase 2 Study
  • Sex: All
  • Age 18+
  • Randomized
  • 200 Participants
Follicular Lymphoma Trial
Follicular Lymphoma Trial

A phase 2, non-randomized clinical trial for treatment with an Anti-CD20 and Anti-CD3 Bispecific Antibody of patients with B-Cell Non-Hodgkin Lymphoma, grades to 3b who have received at least 2 lines of prior systemic therapy.

  • Phase 2 Study
  • Sex: All
  • Age 18+
  • Non-randomized
  • 481 Participants
Stage IV Pancreatic Cancer Trial
Stage IV Pancreatic Cancer Trial

A phase 3, randomized clinical trial for patients with stage IV adenocarcinoma of the pancreas with no prior treatment for metastatic disease.

  • Phase 3 Study
  • Sex: All
  • Age 18+
  • Randomized
  • 750 Participants
Stage III or IV Pancreatic Cancer Trial
Stage III or IV Pancreatic Cancer Trial

A phase 3, randomized clinical trial for patients with stage III or stage IV pancreatic ductal adenocarcinoma who have received only 1 prior line of systemic therapy.

  • Phase 3 Study
  • Sex: All
  • Age 18+
  • Randomized
  • 500 Participants
Non-Small Cell Lung Cancer Trial
Non-Small Cell Lung Cancer Trial

A first-in-human/phase 1/2 clinical trial for patients with non-small cell lung cancer with MET alteration.

  • Phase 1/2, FIH Study
  • Sex: All
  • Age 18+
  • Randomized
  • 102 Participants

Massive Bio’s SYNERGY-AI database combines artificial intelligence, genomic biomarkers, and multi-variate analysis to accelerate clinical trial matching and promote access to promising cancer therapies. We will then help facilitate enrollment into the study by providing support during the transition.

Request Trial Enrollment or Support

Looking for a different trial?

Take advantage of our Clinical Trial Matching Service. Massive Bio is 4x more successful in finding cancer clinical trial matches for patients than any other service provider.